These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14644090)

  • 1. Retroperitoneal hematoma following tirofiban and enoxaparin coadministration in a patient with acute coronary syndrome.
    Aydin M; Ozeren A; Bilge M; Gursurer M; Ozdemir H; Savranlar A
    Thromb Res; 2003; 111(1-2):121-3. PubMed ID: 14644090
    [No Abstract]   [Full Text] [Related]  

  • 2. A word of caution.
    Badaoui G; Kassab R
    Int J Cardiol; 2000; 76(2-3):241-3. PubMed ID: 11229409
    [No Abstract]   [Full Text] [Related]  

  • 3. Activated recombinant factor VII (rFVIIa) in bleeding management after therapy with IIb/IIIa-inhibitor tirofiban.
    Stepinska J; Banaszewski M; Konopka A; Szajewski T
    Thromb Haemost; 2002 Feb; 87(2):355-6. PubMed ID: 11858506
    [No Abstract]   [Full Text] [Related]  

  • 4. Retroperitoneal hematoma following rofecoxib and enoxaparin coadministration in a patient with atrial fibrillation.
    Khan FY; Hassan IF; Allity MH; Khan SM
    Saudi Med J; 2005 Feb; 26(2):336-7. PubMed ID: 15770322
    [No Abstract]   [Full Text] [Related]  

  • 5. Preoperative use of enoxaparin and tirofiban: possible association with increased bleeding postbypass.
    Skubas NJ; Despotis GJ; Vlasnic JJ; Moon MR
    Anesthesiology; 1999 Sep; 91(3):869-72. PubMed ID: 10485801
    [No Abstract]   [Full Text] [Related]  

  • 6. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.
    Ferguson JJ; Antman EM; Bates ER; Cohen M; Every NR; Harrington RA; Pepine CJ; Theroux P;
    Am Heart J; 2003 Oct; 146(4):628-34. PubMed ID: 14564315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroperitoneal hematoma and enoxaparin.
    Montoya JP; Pokala N; Melde SL
    Ann Intern Med; 1999 Nov; 131(10):796-7. PubMed ID: 10577319
    [No Abstract]   [Full Text] [Related]  

  • 8. Enoxaparin-related fatal spontaneous retroperitoneal hematoma in the elderly.
    Vayá A; Mira Y; Aznar J; Todolí J; Arguedas J; Solá E
    Thromb Res; 2003 Apr; 110(1):69-71. PubMed ID: 12877912
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant activated factor VII treatment of retroperitoneal hematoma in a patient with renal failure receiving enoxaparin and clopidogrel.
    Cherfan A; Arabi Y; Al Askar A; Al Shimemeri A
    Pharmacotherapy; 2007 May; 27(5):755-9. PubMed ID: 17461711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemothorax and retroperitoneal hematoma after anticoagulation with enoxaparin.
    Mrug M; Mishra PV; Lusane HC; Cunningham JM; Alpert MA
    South Med J; 2002 Aug; 95(8):936-8. PubMed ID: 12190238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massive retroperitoneal hematoma during enoxaparin treatment of pulmonary embolism after primary total hip arthroplasty: case reports and review of the literature.
    Lee MC; Nickisch F; Limbird RS
    J Arthroplasty; 2006 Dec; 21(8):1209-14. PubMed ID: 17162185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoxaparin-induced spontaneous massive retroperitoneal hematoma with fatal outcome.
    Salemis NS; Oikonomakis I; Lagoudianakis E; Boubousis G; Tsakalakis C; Sourlas S; Gourgiotis S
    Am J Emerg Med; 2014 Dec; 32(12):1559.e1-3. PubMed ID: 24972961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enoxaparin-associated spontaneous retroperitoneal hematoma in elderly patients with impaired creatinine clearance: a report of two cases.
    Uthamalingam S; Vadnerkar A; Brensilver JM
    J Am Geriatr Soc; 2004 Mar; 52(3):477-9. PubMed ID: 14962179
    [No Abstract]   [Full Text] [Related]  

  • 14. Enoxaparin-associated retroperitoneal bleeding in two patients with renal insufficiency.
    Malik A; Capling R; Bastani B
    Pharmacotherapy; 2005 May; 25(5):769-72. PubMed ID: 15899740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A massive retroperitoneal hematoma during low-molecular-weight-heparin therapy.
    Sbrana F; Pasanisi EM
    Intern Emerg Med; 2016 Feb; 11(1):153-4. PubMed ID: 26078200
    [No Abstract]   [Full Text] [Related]  

  • 16. Enoxaparin-associated severe retroperitoneal bleeding and abdominal compartment syndrome: a report of two cases.
    Dabney A; Bastani B
    Intensive Care Med; 2001 Dec; 27(12):1954-7. PubMed ID: 11797033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spontaneous retroperitoneal hematoma induced by enoxiparin to therapeutic dose].
    Gómez de la Torre R; Milla Crespo A; Cadenas F; Fernández Bustamante J; Vázquez Castañón M
    An Med Interna; 2003 Jul; 20(7):386-7. PubMed ID: 12951972
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose tirofiban with enoxaparin and inflammatory markers in high-risk percutaneous intervention.
    Walters DL; Ray MJ; Wood P; Perrin EJ; Bett JH; Aroney CN
    Eur J Clin Invest; 2010 Feb; 40(2):139-47. PubMed ID: 20039931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profound thrombocytopenia associated with tirofiban: case report and review of literature.
    Patel S; Patel M; Din I; Reddy CV; Kassotis J
    Angiology; 2005; 56(3):351-5. PubMed ID: 15889207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abciximab, eptifibatide, and tirofiban: comparison of parenteral glycoprotein IIb/IIIa inhibitors.
    Dunn A
    Conn Med; 1999 Aug; 63(8):483-7. PubMed ID: 10500344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.